Pharma companies caught in the storm of lawsuits can navigate potential reputation damage with planning and purpose (Illustration: Assistant editor Kathy Wong for Endpoints News)
August 30, 2022 12:45 PM EDTUpdated 01:46 PM
Pharma
Marketing

Phar­ma's day in court: Is the dai­ly down­pour of law­suits giv­ing phar­ma com­pa­nies a bad rep?

Beth Snyder Bulik

Senior Editor

Every day seems like law­suit day in the phar­ma in­dus­try. Le­gal fil­ings over patent dis­putes, per­ceived mar­ket­ing mis­steps and ad­verse event drug claims are of­ten …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times